AU2013346803B2 - Single dose recombinant bovine FSH after follicular synchronisation - Google Patents

Single dose recombinant bovine FSH after follicular synchronisation Download PDF

Info

Publication number
AU2013346803B2
AU2013346803B2 AU2013346803A AU2013346803A AU2013346803B2 AU 2013346803 B2 AU2013346803 B2 AU 2013346803B2 AU 2013346803 A AU2013346803 A AU 2013346803A AU 2013346803 A AU2013346803 A AU 2013346803A AU 2013346803 B2 AU2013346803 B2 AU 2013346803B2
Authority
AU
Australia
Prior art keywords
cys
thr
day
lys
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013346803A
Other languages
English (en)
Other versions
AU2013346803A1 (en
Inventor
Aude Carrie
Naomi ISAKA
Alexandre Souza
Dominique Thibaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of AU2013346803A1 publication Critical patent/AU2013346803A1/en
Application granted granted Critical
Publication of AU2013346803B2 publication Critical patent/AU2013346803B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/02—Breeding vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
AU2013346803A 2012-11-16 2013-11-15 Single dose recombinant bovine FSH after follicular synchronisation Active AU2013346803B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306428.9A EP2732824A1 (en) 2012-11-16 2012-11-16 Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone
EP12306428.9 2012-11-16
PCT/EP2013/073928 WO2014076231A1 (en) 2012-11-16 2013-11-15 Single dose recombinant bovine fsh after follicular synchronisation

Publications (2)

Publication Number Publication Date
AU2013346803A1 AU2013346803A1 (en) 2015-05-21
AU2013346803B2 true AU2013346803B2 (en) 2018-03-15

Family

ID=47221997

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013346803A Active AU2013346803B2 (en) 2012-11-16 2013-11-15 Single dose recombinant bovine FSH after follicular synchronisation

Country Status (10)

Country Link
US (2) US20150335713A1 (enExample)
EP (3) EP2732824A1 (enExample)
JP (2) JP6419707B2 (enExample)
CN (2) CN110433281A (enExample)
AU (1) AU2013346803B2 (enExample)
ES (1) ES2743763T3 (enExample)
MX (1) MX373765B (enExample)
RU (1) RU2679944C2 (enExample)
WO (1) WO2014076231A1 (enExample)
ZA (1) ZA201503404B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2782584T3 (pl) 2011-11-23 2021-12-13 Therapeuticsmd, Inc. Naturalne skojarzone hormonalne formulacje i terapie zastępcze
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105727260A (zh) * 2016-02-03 2016-07-06 华侨大学 一种卵泡刺激素的长效制剂
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN107173329A (zh) * 2017-07-07 2017-09-19 宣汉县蜀宣花牛养殖专业合作社 一种蜀宣花牛母牛繁殖方法
CL2018001347A1 (es) * 2018-05-18 2019-03-15 Centro De Biotecnologia Y Biomedicina Spa 94% Hormona folículo estimulante bovina recombinante, composición que la comprende y método para inducir superovulación y sincronización del celo en bovinos utilizando dicha hormona
CN114258302A (zh) * 2019-08-01 2022-03-29 法国诗华大药厂 用于预防和/或治疗隐孢子虫病的兽用组合物
EP4504238A1 (en) 2022-04-01 2025-02-12 Ceva Santé Animale Increase of ovum pick-up in bos taurus
WO2023187160A1 (en) 2022-04-01 2023-10-05 Ceva Sante Animale Stimulation of superovulation in bos taurus
CN116027053B (zh) * 2022-09-27 2024-10-08 华中农业大学 一种竞争型草鱼卵泡刺激素检测试剂盒及应用
CN117089512A (zh) * 2023-08-21 2023-11-21 山东奥克斯畜牧种业有限公司 一种促进卵泡同步发育的制剂及牛体外胚胎生产方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1729352A1 (ru) * 1987-11-25 1992-04-30 Украинский Научно-Исследовательский Институт Физиологии И Биохимии Сельскохозяйственных Животных Способ вызывани полиовул ции у коров-доноров при трансплантации эмбрионов
US6238890B1 (en) 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
US5589457A (en) 1995-07-03 1996-12-31 Ausa International, Inc. Process for the synchronization of ovulation
JPH09104638A (ja) * 1995-10-06 1997-04-22 Mitsui Pharmaceut Inc 医薬・動物薬組成物
US20090036384A1 (en) 2005-12-02 2009-02-05 Parnell Laboratories (Aust) Pty Limited Increasing pregnancy rates
US8518881B2 (en) 2007-02-08 2013-08-27 Aspenbio Pharma, Inc. Methods for inducing superovulation in ungulates
BRPI0821097A2 (pt) 2007-11-30 2017-05-23 Aspenbio Pharma Inc aitividade de hormônio equino folículo estimulante recombinante
WO2009103965A1 (en) * 2008-02-19 2009-08-27 Asterion Limited Modified linkers
JP5435422B2 (ja) * 2009-07-21 2014-03-05 独立行政法人農業・食品産業技術総合研究機構 ウシの発情同期化法およびそのためのキット

Also Published As

Publication number Publication date
ES2743763T3 (es) 2020-02-20
EP3520807A1 (en) 2019-08-07
JP2016502523A (ja) 2016-01-28
AU2013346803A1 (en) 2015-05-21
CN104918631A (zh) 2015-09-16
JP2018168189A (ja) 2018-11-01
ZA201503404B (en) 2016-08-31
WO2014076231A1 (en) 2014-05-22
RU2015122887A (ru) 2017-01-10
US20150335713A1 (en) 2015-11-26
JP6419707B2 (ja) 2018-11-07
JP6823013B2 (ja) 2021-01-27
MX373765B (es) 2020-03-24
US20190200587A1 (en) 2019-07-04
EP2732824A1 (en) 2014-05-21
RU2679944C2 (ru) 2019-02-14
EP2919803B1 (en) 2019-05-08
CN110433281A (zh) 2019-11-12
MX2015006141A (es) 2015-08-05
EP2919803A1 (en) 2015-09-23

Similar Documents

Publication Publication Date Title
AU2013346803B2 (en) Single dose recombinant bovine FSH after follicular synchronisation
US8835386B2 (en) Activity of recombinant equine follicle stimulating hormone
Goel et al. Ovulatory response and embryo yield in Jakhrana goats following treatments with PMSG and FSH
US20220143131A1 (en) Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone
WO2023187162A1 (en) Increase of ovum pick-up in bos taurus
WO2020061612A1 (en) Method for enhancing assisted breeding techniques
US20250222073A1 (en) Stimulation of superovulation in bos taurus
US20250387452A1 (en) Increase of ovum pick-up in bos taurus
Sengül et al. Effect of royal jelly on puberty of ewe lambs
Kharche et al. Superovulatory response and embryo production efficiency in goats following pretreatment with heG and estradiol-I7B
CN117298256A (zh) 一种提高牦牛生殖性能的促性腺激素组合物及其施用方法
Price Induction of multiple ovulation in farm species: successes and heroic failures.
JPH03117446A (ja) Ｆｓｈによる牛の双子生産方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)